A critical role of interferon-induced protein IFP35 in the type I interferon response in cells induced by foot-and-mouth disease virus (FMDV) protein 2C

Archives of Virology

Volumn 159, Issue 11, 2014, Pages 2925-2935

  Zheng, Wei ^a,b   Li, Xiaying ^b   Wang, Jianchang ^b   Li, Xiaoqi ^b   Cao, Hong ^b   Wang, Yongqiang ^b   Zeng, Qinghua ^a   Zheng, Shijun J ^b  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOOT-AND-MOUTH DISEASE VIRUS; VESICULAR STOMATITIS VIRUS;

IFI35 PROTEIN, HUMAN; INTERFERON; NMI PROTEIN, HUMAN; PROTEIN BINDING; SIGNAL PEPTIDE; VIRUS PROTEIN;

ANIMAL; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIROLOGY;

ANIMALS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; HUMANS; INTERFERON TYPE I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN BINDING; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84919380933     PISSN: 03048608     EISSN: 14328798     Source Type: Journal    
DOI: 10.1007/s00705-014-2147-7     Document Type: Article

References (42)

1. Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17:465–493
2. Saiz M, Nunez JI, Jimenez-Clavero MA, Baranowski E, Sobrino F (2002) Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect 4:1183–1192
3. Gorbalenya AE, Koonin EV (1989) Viral proteins containing the purine NTP-binding sequence pattern. Nucleic Acids Res 17:8413–8440
4. Echeverri A, Banerjee R, Dasgupta A (1998) Amino-terminal region of poliovirus 2C protein is sufficient for membrane binding. Virus Res 54:217–223
5. Banerjee R, Dasgupta A (2001) Interaction of picornavirus 2C polypeptide with the viral negative-strand RNA. J Gen Virol 82:2621–2627
6. Rodriguez PL, Carrasco L (1995) Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem 270:10105–10112
7. Rodriguez PL, Carrasco L (1993) Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem 268:8105–8110
8. Pfister T, Jones KW, Wimmer E (2000) A cysteine-rich motif in poliovirus protein 2C(ATPase) is involved in RNA replication and binds zinc in vitro. J Virol 74:334–343
9. Sweeney TR, Cisnetto V, Bose D, Bailey M, Wilson JR et al (2010) Foot-and-mouth disease virus 2C is a hexameric AAA + protein with a coordinated ATP hydrolysis mechanism. J Biol Chem 285:24347–24359
10. Tang WF, Yang SY, Wu BW, Jheng JR, Chen YL et al (2007) Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J Biol Chem 282:5888–5898
11. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Rinaudo MS et al (2006) Testing the modularity of the N-terminal amphipathic helix conserved in picornavirus 2C proteins and hepatitis C NS5A protein. Virology 344:453–467
12. Bienz K, Egger D, Troxler M, Pasamontes L (1990) Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J Virol 64:1156–1163
13. Moffat K, Howell G, Knox C, Belsham GJ, Monaghan P et al (2005) Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J Virol 79:4382–4395
14. Moffat K, Knox C, Howell G, Clark SJ, Yang H et al (2007) Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J Virol 81:1129–1139
15. Wang J, Wang Y, Liu J, Ding L, Zhang Q et al (2012) A critical role of N-myc and STAT interactor (Nmi) in foot-and-mouth disease virus (FMDV) 2C-induced apoptosis. Virus Res 170:59–65
16. Payvandi F, Amrute S, Fitzgerald-Bocarsly P (1998) Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J Immunol 160:5861–5868
17. Sharma P, Kumar S, Kundu GC (2010) Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Mol Cancer 9:178
18. Palomares RA, Walz HG, Brock KV (2013) Expression of type I interferon-induced antiviral state and pro-apoptosis markers during experimental infection with low or high virulence bovine viral diarrhea virus in beef calves. Virus Res 173:260–269
19. Lechner J, Malloth N, Seppi T, Beer B, Jennings P et al (2008) IFN-alpha induces barrier destabilization and apoptosis in renal proximal tubular epithelium. Am J Physiol Cell Physiol 294:C153–C160
20. Thyrell L, Hjortsberg L, Arulampalam V, Panaretakis T, Uhles S et al (2004) Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway. J Biol Chem 279:24152–24162
21. Le Page C, Genin P, Baines MG, Hiscott J (2000) Interferon activation and innate immunity. Rev Immunogenet 2:374–386
22. Li X, Wang J, Liu J, Li Z, Wang Y et al (2013) Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells. Vet Microbiol 166:35–46
23. Hou F, Liu K, Shen T, Zhou B, Cao R et al (2011) Antiviral activity of rChIFN-alpha against vesicular stomatitis virus and Newcastle disease virus: a novel recombinant chicken interferon-alpha showed high antiviral activity. Res Vet Sci 91:e73–e79
24. Trottier MJ, Palian BM, Reiss CS (2005) VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 333:215–225
25. Tan J, Qiao W, Wang J, Xu F, Li Y et al (2008) IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus. J Virol 82:4275–4283
26. Zhang L, Tang Y, Tie Y, Tian C, Wang J et al (2007) The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling. Cell Signal 19:932–944
27. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E (1997) Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol 71:8962–8972
28. Echeverri AC, Dasgupta A (1995) Amino terminal regions of poliovirus 2C protein mediate membrane binding. Virology 208:540–553
29. Schlegel A, Giddings TJ, Ladinsky MS, Kirkegaard K (1996) Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol 70:6576–6588
30. Lippincott-Schwartz J (1993) Bidirectional membrane traffic between the endoplasmic reticulum and Golgi apparatus. Trends Cell Biol 3:81–88
31. Bange FC, Vogel U, Flohr T, Kiekenbeck M, Denecke B et al (1994) IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. J Biol Chem 269:1091–1098
32. Lee ND, Chen J, Shpall RL, Naumovski L (1999) Subcellular localization of interferon-inducible Myc/stat-interacting protein Nmi is regulated by a novel IFP 35 homologous domain. J Interferon Cytokine Res 19:1245–1252
33. Chen J, Shpall RL, Meyerdierks A, Hagemeier M, Bottger EC et al (2000) Interferon-inducible Myc/STAT-interacting protein Nmi associates with IFP 35 into a high molecular mass complex and inhibits proteasome-mediated degradation of IFP 35. J Biol Chem 275:36278–36284
34. Zhou X, Liao J, Meyerdierks A, Feng L, Naumovski L et al (2000) Interferon-alpha induces nmi-IFP35 heterodimeric complex formation that is affected by the phosphorylation of IFP35. J Biol Chem 275:21364–21371
35. Wang X, Johansen LM, Tae HJ, Taparowsky EJ (1996) IFP 35 forms complexes with B-ATF, a member of the AP1 family of transcription factors. Biochem Biophys Res Commun 229:316–322
36. Wang J, Yang B, Hu Y, Zheng Y, Zhou H et al (2013) Negative regulation of Nmi on virus-triggered type I IFN production by targeting IRF7. J Immunol 191:3393–3399
37. Das A, Dinh PX, Panda D, Pattnaik AK (2014) Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication. J Virol 88:3103–3113
38. Han KJ, Su X, Xu LG, Bin LH, Zhang J et al (2004) Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem 279:15652–15661
39. Yan Q, Carmody RJ, Qu Z, Ruan Q, Jager J et al (2012) Nuclear factor-kappaB binding motifs specify toll-like receptor-induced gene repression through an inducible repressosome. Proc Natl Acad Sci USA 109:14140–14145
40. Fillmore RA, Mitra A, Xi Y, Ju J, Scammell J et al (2009) Nmi (N-myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int J Cancer 125:556–564
41. Chinsangaram J, Piccone ME, Grubman MJ (1999) Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol 73:9891–9898
42. de Los ST, de Avila BS, Weiblen R, Grubman MJ (2006) The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol 80:1906–1914